IL-33-Activated ILC2s Induce Tertiary Lymphoid Structures in Pancreatic Cancer

In mice, IL-33 deficiency severely attenuated inflammation- and lymphotoxin (LT)–LTβ receptor-activation-induced tertiary lymphoid structures in models of colitis and PDAC.